DBK Pharma plans dual listing on EGX, TASI by H1 2019
Pharmaceutical firm is considering to offer about 25% stake on two markets
DBK Pharma targets to offer 30% of its shares on EGX in Q1 of 2017
The promotion of this IPO requires effective action, especially after the failure…
